Tantech Regains Compliance With Nasdaq
Tantech Holdings Ltd (NASDAQ:TANH) ("Tantech" or the "Company"), a clean energy company, today announced it received notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming the
X4 Pharma To Stop Further Work On Oncology Programs, Looks For Partner(s)
X4 Pharmaceuticals Inc (NASDAQ:XFOR) updated its strategic priorities that include streamlining resources to focus on advancing its lead candidate, mavorixafor, in…
Incannex Receives Ethics Approval To Commence Phase 1 Clinical Trial Of Multi-Use Anti-Inflammatory Drug IHL-675A
Highlights:
Bellberry human research ethics committee approved the phase 1 clinical trial investigating safety and pharmacokinetics of IHL-675A on July 20, 2022
The trial will be performed at CMAX Clinical
Olema Oncology Receives FDA Fast Track Designation For OP-1250 For Treatment Of ER+ / HER2- Metastatic Breast Cancer
Olema Pharmaceuticals, Inc. ((&ldquo, Olema&rdquo, or &ldquo, Olema Oncology, &rdquo, NASDAQ:OLMA) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to OP-1250, the
Danaher Easily Beats Q2 Street View With Growth From Base Business; FY22 Outlook Unchanged
Danaher Corp (NYSE:DHR) has logged Q2 FY22 adjusted EPS of $2.76, up 12% Y/Y, surpassing the estimate of $2.35. Sales…
Disappointing Data Forces Assembly Bio Stop Combo Trial For HBV Infection
Assembly Biosciences Inc (NASDAQ:ASMB) will stop working on its first-generation core inhibitor, vebicorvir (VBR), as it prioritizes its next-gen core…
Crown Holdings Cuts FY22 Earnings Forecast Despite Q2 Beat
Crown Holdings Inc (NYSE:CCK) reported second-quarter FY22 sales growth of 22.9% year-on-year, to $3.51 billion, beating the consensus of $3.21 billion.…
Remember Elon Musk And Christine Baranski’s Viral ‘Death Stare’ Met Gala Photo? Actress Finally Reveals What Was Going On
American actress and comedian Christine Baranski said that her cold stare at Tesla Inc (NASDAQ: TSLA) CEO Elon Musk during the Met Gala in May was fueled by disdain.
Biogen Reveals $900M Settlement In Whistleblower’s MS Drug Kickbacks Lawsuit Days Before Trial
Biogen, Inc. (NASDAQ: BIIB) disclosed in its second-quarter earnings report that it recorded $900 million related to a settlemen
Tesla Hasn’t Sold Any Dogecoin, But Elon Musk Says Bitcoin Sale ‘Shouldn’t Be Taken As A Verdict’
Tesla Inc (NASDAQ: TSLA) reported its second-quarter earnings after the closing bell on Wednesday, beating analysts’ top and bottom line estimates.
Here are key figures from the report compared with Wall Street's predictions.